Tab Application Banner
  • Users Online: 269
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
PREFACE
Year : 2020  |  Volume : 15  |  Issue : 6  |  Page : 73

Inflammatory myositis - Foray into the future


1 Department of Pharmacy and Pharmacology, Royal National Hospital for Rheumatic Diseases, Bath, UK
2 Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

Date of Submission17-Nov-2020
Date of Acceptance16-Dec-2020
Date of Web Publication18-Jan-2021

Correspondence Address:
Dr. Latika Gupta
Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-3698.238193

Rights and Permissions

How to cite this article:
McHugh N, Gupta L. Inflammatory myositis - Foray into the future. Indian J Rheumatol 2020;15:73

How to cite this URL:
McHugh N, Gupta L. Inflammatory myositis - Foray into the future. Indian J Rheumatol [serial online] 2020 [cited 2021 Mar 8];15:73. Available from: https://www.indianjrheumatol.com/text.asp?2020/15/6/73/238193







Idiopathic inflammatory myositis (IIM) is rare and heterogeneous, and the field is rapidly evolving with newer insights being offered by the discovery of newer autoantibodies and a greater understanding of the disease through collaborative studies on the rare groups of diseases. Through this special supplement on myositis, we hope to review recent literature for key insights into the various forms of disease and management in the clinics. We begin with a history of myositis research from India and go on to discuss the never-ending debate on the utility of autoantibodies versus biopsy, followed by discussions on the pathogenesis of IIM and the various overlap forms of myositis, cancer-associated myositis, statin-associated muscle disorders, and sporadic inclusion body myositis and controversies in the management of juvenile dermatomyositis. The emerging spectrum of the antisynthetase syndrome and rapidly progressive lung disease in the setting of IIM is covered in depth by two scoping reviews on the subject.

Myositis being a rare disease, collaborative efforts are needed to gather meaningful multicenter data. Unified case-record forms (CRFs) and biobanking are essential to such efforts. Two-method papers describe the setting up of a biobank and digitally archived dataset collected on a unified CRF in India. Further, we discuss original studies on the differential diagnosis of polymyositis in the clinic, a new biomarker on IIM, and the utility of intravenous immunoglobulin in the Indian setting. Three case reports highlight an atypical presentation of the antisynthetase syndrome and sarcoidosis-associated myositis and the successful treatment of juvenile dermatomyositis with tacrolimus.

While physician perspectives are oft explored, patient perspectives are less discussed and poorly understood. In the post-COVID era of social distancing and remote chronic care, patient-reported outcome measures may be the new norm. Moreover, fighting a chronic illness may entail more than meets the eye, and a better understanding of the mental and emotional struggle and community support needed to help these individuals may go a long way in improving patient care. We have featured unique patient perspectives, in an interview with Amber O' Connor, and another one by a student clinician, highlighting the issues that are less discussed.

Scientific writing is an art, and with this supplement, we have also tried to revive some art forms such as cartoons and poetry relevant to the disease. As they say, a picture is a poem without words, and we hope to explore both domains of visual and prose art in this new endeavor of the likes of JAMA and Lancet.

We hope that this supplement will delight the readers with up-to-date information and help them gather fresh perspectives!

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.






 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article

 Article Access Statistics
    Viewed535    
    Printed20    
    Emailed0    
    PDF Downloaded125    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]